Advertisement
Sigma-Aldrich
Sigma-Aldrich

The Scientist

» pharmaceuticals and disease/medicine

Most Recent

image: Pluripotency Bots

Pluripotency Bots

By | January 1, 2016

A tour of efforts to automate the production and differentiation of induced pluripotent stem cells

0 Comments

image: Picking Up the Pace

Picking Up the Pace

By | January 1, 2016

FDA designations promise to expedite the approval of drugs for conditions ranging from infectious disease to cancer.

0 Comments

image: Viral Soldiers

Viral Soldiers

By | January 1, 2016

Phage therapy to combat bacterial infections is garnering attention for the second time in 100 years, but solid clinical support for its widespread use is still lacking.

11 Comments

image: Second Contagious Cancer Found in Tasmanian Devils

Second Contagious Cancer Found in Tasmanian Devils

By | December 29, 2015

A second fatal, transmissible cancer has been identified in the already endangered species.  

0 Comments

image: Bayer Enters CRISPR Field

Bayer Enters CRISPR Field

By | December 22, 2015

The pharmaceutical company will spend $335 million on a new venture with biotech startup CRISPR Therapeutics.

0 Comments

image: Year in Review: Hot Topics

Year in Review: Hot Topics

By | December 21, 2015

In 2015, The Scientist dove deep into the latest research on aging, HIV, hearing, and obesity.

0 Comments

image: When the Flu Vax Fails

When the Flu Vax Fails

By | December 16, 2015

The status of a person’s immune system can predict when a seasonal flu vaccination will not provide sufficient protection, according to a study. 

0 Comments

image: First Dengue Vax Approved

First Dengue Vax Approved

By | December 11, 2015

Mexico’s health ministry has OKed the vaccine for people between nine and 45 years old.

0 Comments

image: Global Food-Related Disease Estimate

Global Food-Related Disease Estimate

By | December 7, 2015

More than 400,000 people—including 125,000 children—die from foodborne illness every year, according to the World Health Organization.

0 Comments

image: The Regenerator

The Regenerator

By | December 1, 2015

In his search for effective therapies for Parkinson’s disease, Lorenz Studer is uncovering pluripotency switches and clues to what makes cells age.

0 Comments

Popular Now

  1. Antibody Alternatives
    Features Antibody Alternatives

    Nucleic acid aptamers and protein scaffolds could change the way researchers study biological processes and treat disease.

  2. The Mycobiome
    Features The Mycobiome

    The largely overlooked resident fungal community plays a critical role in human health and disease.

  3. Circadian Clock and Aging
    Daily News Circadian Clock and Aging

    Whether a critical circadian clock gene is deleted before or after birth impacts the observed aging-related effects in mice.

  4. Biologist Resigns Amid Sexual Misconduct Probe
Advertisement
Lexogen
Lexogen
Advertisement
Life Technologies